China’s National Adverse Drug Reaction Report for 2023 Highlights Stability in Reporting Trends
The National Center for ADR Monitoring has released its “National Adverse Drug Reaction Monitoring Annual...
Fineline Cube
Lee’s Pharmaceutical Holdings Ltd Reports 2023 Financials with Focus Shift to Patented and Generic Drugs
Lee’s Pharmaceutical Holdings Ltd (HKG: 0950), a leading pharmaceutical company based in China, has released...
Hansoh Pharmaceutical Group Reports 7.7% YOY Revenue Growth and Expands R&D Spending
Hansoh Pharmaceutical Group Co., Ltd (HKG: 3692) has announced its financial results for 2023, reporting...
Shanghai Pharmaceuticals, SHC, and CEMCS CAS Renew Partnership to Incubate Pharmaceutical Innovations
Shanghai Pharmaceuticals Holding Co., Ltd. (SPH, SHA: 601607; HKG: 2607), a leading pharmaceutical company in...
Kobayashi Pharmaceutical Recalls Red Yeast Rice Pills in China Amid Health Concerns
Japan-based Kobayashi Pharmaceutical has reportedly initiated a product recall in the Chinese market for its...
Surprise Resignation: Congressman Gallagher Steps Down as Biosecure Act Faces Uncertainty
U.S. Congressman Mike Gallagher, the key proponent behind the recently introduced Biosecure Act aimed at...
Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Deal Amid Biotech Pressures
U.S.-based biotech Nuvation Bio Inc. (NYSE: NUVB) has announced a definitive agreement to acquire China-based...
FDA Grants Full Approval to AbbVie’s Elahere for Advanced Ovarian Cancer Treatment
This week, the U.S. Food and Drug Administration (FDA) granted full approval to AbbVie’s (NYSE:...
Fosun Health and Adventist Medical Center Partner to Enhance GBA Medical Services
China-based Fosun Health Consumption Industry Group has entered into a strategic partnership with Hong Kong’s...
Biocytogen and ABL Bio Forge Partnership to Advance Bispecific ADC Development
China-based Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG: 2315) has entered into a partnership with South...
HitGen Secures Strategic Partnerships to Enhance Drug Discovery for Startups
China-based HitGen Inc. (SHA: 688222) has announced strategic partnerships with LabCentral, a prominent life science...
CanSino Biologics Launches Phase III Study for Menhycia Vaccine in Indonesia
China-based CanSino Biologics (HKG: 6185) has announced the launch of a Phase III clinical study...
Novo Nordisk Acquires Cardior for €1.025 Billion to Strengthen Cardiovascular Portfolio
Denmark-based Novo Nordisk (CPH: NOVO-B) has announced a significant agreement to acquire Germany’s Cardior, a...
Kelun-Biotech Reports Robust 91.6% Revenue Growth Amid Strategic Licensing Efforts
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990) reported its 2023 financial results, revealing revenues of...
Guangdong Zhongsheng Reports Positive Phase I Results for Innovative Weight Loss Drug RAY1225
Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317), a China-based biopharmaceutical company, has announced promising top-line...
Zylox-Tonbridge Secures NMPA Approval for Advanced Flow Diverter Targeting Intracranial Aneurysms
Zylox-Tonbridge Medical Technology (HKG: 2190), a China-based developer of nerve and peripheral vascular interventional devices,...
Novo Nordisk Expands Benzalkonium Chloride Distribution with Actylis Across Europe
Denmark’s Novo Nordisk (CPH: NOVO-B), through its Pharmatech division, announced a partnership this week with...
WuXi XDC Reports 114.4% YOY Revenue Growth in 2023, Driven by ADC CRDMO Business
WuXi XDC (HKG: 2268), a joint venture between WuXi Biologics (HKG: 2269) and WuXi STA,...
Jiangsu Hengrui’s Generic Version of Tepadina Approved for Transplantation Conditioning in China
Jiangsu Hengrui Pharmaceuticals Co., Ltd (SHA: 600276), a leading pharmaceutical company based in China, has...
MSD’s Phase III Trial of Keytruda Plus Lynparza Misses Primary Endpoints in NSCLC
Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced an unfavorable outcome for a Phase...